Skip to main content
OpenTrials

Clinical trial condition

Parkinsonian Disorders

Explore clinical trials studying Parkinsonian Disorders. Study availability and eligibility vary by location and protocol.

26 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Parkinsonian Disorders trial results

Completed

Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

NCT03065192

Conditions
Basal Ganglia Disease, Basal Ganglia Diseases, Brain Diseases, +9 more
Locations
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
  • Ohio State University (OSU) Columbus, Ohio, United States
  • University of Pittsburgh Medical Center (UPMC) Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01491932

Conditions
Anti-Dyskinesia Agents, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations
  • Novartis Investigative Site Englewood, Colorado, United States
  • Novartis Investigative Site Kansas City, Kansas, United States
  • Novartis Investigative Site Milwaukee, Wisconsin, United States
  • Novartis Investigative Site Innsbruck, Austria
View all 32 locations
View Trial Details
Completed

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01491529

Conditions
Anti-Dyskinesia Agents, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations
  • Novartis Investigative Site Sunnyvale, California, United States
  • Novartis Investigative Site Englewood, Colorado, United States
  • Novartis Investigative Site Tampa, Florida, United States
  • Novartis Investigative Site Kansas City, Kansas, United States
View all 39 locations
View Trial Details
Completed

Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01385592

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • Novartis Investigative Site Sunnyvale, California, United States
  • Novartis Investigative Site Englewood, Colorado, United States
  • Novartis Investigative Site London, Ontario, Canada
  • Novartis Investigative Site Gatineau, Quebec, Canada
View all 28 locations
View Trial Details

Related conditions